Geneos Wealth Management’s Nutanix NTNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.78K | Hold |
35
| – | – | ﹤0.01% | 2345 |
|
|
2026
Q1 | $1.33K | Hold |
35
| – | – | ﹤0.01% | 2370 |
|
|
2025
Q4 | $1.81K | Hold |
35
| – | – | ﹤0.01% | 2333 |
|
|
2025
Q3 | $2.6K | Hold |
35
| – | – | ﹤0.01% | 2281 |
|
|
2025
Q2 | $2.67K | Sell |
35
-24
| -41% | -$1.73K | ﹤0.01% | 2747 |
|
|
2025
Q1 | $4.12K | Buy |
59
+14
| +31% | +$969 | ﹤0.01% | 2583 |
|
|
2024
Q4 | $2.75K | Hold |
45
| – | – | ﹤0.01% | 2512 |
|
|
2024
Q3 | $2.67K | Buy |
45
+10
| +29% | +$549 | ﹤0.01% | 2233 |
|
|
2024
Q2 | $1.99K | Hold |
35
| – | – | ﹤0.01% | 1888 |
|
|
2024
Q1 | $2.16K | Hold |
35
| – | – | ﹤0.01% | 1887 |
|
|
2023
Q4 | $1.67K | Hold |
35
| – | – | ﹤0.01% | 1949 |
|
|
2023
Q3 | $1.22K | Hold |
35
| – | – | ﹤0.01% | 2005 |
|
|
2023
Q2 | $982 | Hold |
35
| – | – | ﹤0.01% | 2019 |
|
|
2023
Q1 | $910 | Hold |
35
| – | – | ﹤0.01% | 2000 |
|
|
2022
Q4 | $912 | Hold |
35
| – | – | ﹤0.01% | 1974 |
|
|
2022
Q3 | $0 | Sell |
35
-200
| -85% | -$3.65K | ﹤0.01% | 2398 |
|
|
2022
Q2 | $3K | Hold |
235
| – | – | ﹤0.01% | 2325 |
|
|
2022
Q1 | $6K | Hold |
235
| – | – | ﹤0.01% | 2280 |
|
|
2021
Q4 | $7K | Hold |
235
| – | – | ﹤0.01% | 2307 |
|
|
2021
Q3 | $9K | Hold |
235
| – | – | ﹤0.01% | 2262 |
|
|
2021
Q2 | $9K | Sell |
235
-1,603
| -87% | -$49.9K | ﹤0.01% | 2237 |
|
|
2021
Q1 | $49K | Buy |
1,838
+908
| +98% | +$27.6K | ﹤0.01% | 1644 |
|
|
2020
Q4 | $6K | Buy |
930
+730
| +365% | +$19.8K | ﹤0.01% | 2427 |
|
|
2020
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 2269 |
|
|
2020
Q2 | $4K | Hold |
200
| – | – | ﹤0.01% | 2222 |
|
|
2020
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 2188 |
|
|
2019
Q4 | $6K | Sell |
200
-40
| -17% | -$1.18K | ﹤0.01% | 2147 |
|
|
2019
Q3 | $6K | Sell |
240
-770
| -76% | -$18.2K | ﹤0.01% | 2065 |
|
|
2019
Q2 | $26K | Buy |
1,010
+150
| +17% | +$5.23K | ﹤0.01% | 1511 |
|
|
2019
Q1 | $32K | Buy |
860
+410
| +91% | +$18.8K | ﹤0.01% | 1360 |
|
|
2018
Q4 | $18K | Buy |
450
+250
| +125% | +$10.3K | ﹤0.01% | 1548 |
|
|
2018
Q3 | $8K | Sell |
200
-425
| -68% | -$22.4K | ﹤0.01% | 1925 |
|
|
2018
Q2 | $32K | Buy |
625
+425
| +213% | +$23.4K | ﹤0.01% | 1255 |
|
|
2018
Q1 | $9K | Hold |
200
| – | – | ﹤0.01% | 1688 |
|
|
2017
Q4 | $7K | Hold |
200
| – | – | ﹤0.01% | 1744 |
|
|
2017
Q3 | $4K | Buy |
+200
| New | +$4.38K | ﹤0.01% | 1830 |
|
Other funds holding NTNX
GIM
JCAM
Geneos Wealth Management's NTNX Position: Q2 2026 in Review
Geneos Wealth Management held its Nutanix (NTNX) position steady in Q2 2026 at 35 shares worth $1.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2345.
Geneos Wealth Management first reported a position in NTNX in Q3 2017 and has held it in 36 quarters since. The position peaked at $49K in Q1 2021. 564 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.
- Geneos Wealth Management held 35 shares of Nutanix worth $1.78K as of Q2 2026.
- Geneos Wealth Management left its Nutanix share count unchanged in Q2 2026.
- Nutanix made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2345 holding.
- Geneos Wealth Management first reported a position in Nutanix in Q3 2017 and has held it in 36 quarters since.
- Geneos Wealth Management's Nutanix position peaked at $49K in Q1 2021.
- 564 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.